Head-To-Head Contrast: Clearwater Paper (CLW) & Its Competitors

Clearwater Paper (NYSE: CLW) is one of 22 publicly-traded companies in the “PAPER” industry, but how does it compare to its peers? We will compare Clearwater Paper to related businesses based on the strength of its risk, valuation, profitability, institutional ownership, earnings, dividends and analyst recommendations.

Analyst Ratings

How to Become a New Pot Stock Millionaire

This is a breakdown of recent ratings and recommmendations for Clearwater Paper and its peers, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Clearwater Paper 0 2 1 0 2.33
Clearwater Paper Competitors 128 471 531 31 2.40

Clearwater Paper presently has a consensus price target of $43.00, suggesting a potential upside of 16.22%. As a group, “PAPER” companies have a potential upside of 12.32%. Given Clearwater Paper’s higher possible upside, analysts clearly believe Clearwater Paper is more favorable than its peers.

Profitability

This table compares Clearwater Paper and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Clearwater Paper 5.63% 7.12% 2.09%
Clearwater Paper Competitors 18.25% 10.77% 3.69%

Insider & Institutional Ownership

87.6% of Clearwater Paper shares are held by institutional investors. Comparatively, 64.8% of shares of all “PAPER” companies are held by institutional investors. 2.4% of Clearwater Paper shares are held by company insiders. Comparatively, 5.7% of shares of all “PAPER” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Risk & Volatility

Clearwater Paper has a beta of 1.07, indicating that its share price is 7% more volatile than the S&P 500. Comparatively, Clearwater Paper’s peers have a beta of 0.79, indicating that their average share price is 21% less volatile than the S&P 500.

Earnings & Valuation

This table compares Clearwater Paper and its peers gross revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Clearwater Paper $1.73 billion $97.33 million 6.31
Clearwater Paper Competitors $5.69 billion $1.15 billion 14.71

Clearwater Paper’s peers have higher revenue and earnings than Clearwater Paper. Clearwater Paper is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Summary

Clearwater Paper peers beat Clearwater Paper on 10 of the 13 factors compared.

Clearwater Paper Company Profile

Clearwater Paper Corporation manufactures consumer tissue, away-from-home (AFH) tissue, parent roll tissue, bleached paperboard and pulp at manufacturing facilities across the nation. The Company operates through two segments: Consumer Products segment, and Pulp and Paperboard segment. The Company’s Consumer Products segment manufactures and sells a line of at-home tissue products, as well as AFH products. The Company’s Pulp and Paperboard segment manufactures and markets bleached paperboard for the packaging industry. It is a producer of solid bleach sulfate (SBS) paperboard. The Company is a supplier of private label tissue to a range of retailers and wholesale distributors, including grocery, drug, mass merchants and discount stores. In addition, the Company produces bleached paperboard used by printers and packaging converters, and offers services that include custom sheeting, slitting and cutting.

Receive News & Ratings for Clearwater Paper Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clearwater Paper and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Dogecoin  Price Reaches $0.0051
Dogecoin Price Reaches $0.0051
NuBits  Trading 5% Lower  Over Last 7 Days
NuBits Trading 5% Lower Over Last 7 Days
Stratis Market Capitalization Achieves $569.21 Million
Stratis Market Capitalization Achieves $569.21 Million
Foundation Medicine  Receives Consensus Recommendation of “Hold” from Analysts
Foundation Medicine Receives Consensus Recommendation of “Hold” from Analysts
US Foods Holding Corp.  Expected to Post Earnings of $0.31 Per Share
US Foods Holding Corp. Expected to Post Earnings of $0.31 Per Share
Alexion Pharmaceuticals  Given Average Rating of “Buy” by Analysts
Alexion Pharmaceuticals Given Average Rating of “Buy” by Analysts


© 2006-2018 Ticker Report. Google+.